CN105228632A - 一种用以将一群治疗细胞维持在需要接受细胞治疗个体体内的治疗位置的方法 - Google Patents

一种用以将一群治疗细胞维持在需要接受细胞治疗个体体内的治疗位置的方法 Download PDF

Info

Publication number
CN105228632A
CN105228632A CN201480008940.3A CN201480008940A CN105228632A CN 105228632 A CN105228632 A CN 105228632A CN 201480008940 A CN201480008940 A CN 201480008940A CN 105228632 A CN105228632 A CN 105228632A
Authority
CN
China
Prior art keywords
cells
stem cells
hyaluronic acid
therapeutic
group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201480008940.3A
Other languages
English (en)
Chinese (zh)
Inventor
谢清河
赖佳昀
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CN105228632A publication Critical patent/CN105228632A/zh
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/48—Reproductive organs
    • A61K35/54—Ovaries; Ova; Ovules; Embryos; Foetal cells; Germ cells
    • A61K35/545—Embryonic stem cells; Pluripotent stem cells; Induced pluripotent stem cells; Uncharacterised stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/728—Hyaluronic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/28—Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/32—Bones; Osteocytes; Osteoblasts; Tendons; Tenocytes; Teeth; Odontoblasts; Cartilage; Chondrocytes; Synovial membrane
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/34—Muscles; Smooth muscle cells; Heart; Cardiac stem cells; Myoblasts; Myocytes; Cardiomyocytes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/35—Fat tissue; Adipocytes; Stromal cells; Connective tissues
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/36—Skin; Hair; Nails; Sebaceous glands; Cerumen; Epidermis; Epithelial cells; Keratinocytes; Langerhans cells; Ectodermal cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/48—Reproductive organs
    • A61K35/50—Placenta; Placental stem cells; Amniotic fluid; Amnion; Amniotic stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/48—Reproductive organs
    • A61K35/51—Umbilical cord; Umbilical cord blood; Umbilical stem cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Cell Biology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Virology (AREA)
  • Zoology (AREA)
  • Reproductive Health (AREA)
  • Dermatology (AREA)
  • Hematology (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Molecular Biology (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Materials For Medical Uses (AREA)
CN201480008940.3A 2013-02-15 2014-02-14 一种用以将一群治疗细胞维持在需要接受细胞治疗个体体内的治疗位置的方法 Pending CN105228632A (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201361765075P 2013-02-15 2013-02-15
US61/765,075 2013-02-15
PCT/US2014/016477 WO2014127232A2 (fr) 2013-02-15 2014-02-14 Méthodes destinées à maintenir une population de cellules thérapeutiques sur le site de traitement chez un sujet ayant besoin d'une thérapie cellulaire

Publications (1)

Publication Number Publication Date
CN105228632A true CN105228632A (zh) 2016-01-06

Family

ID=51354685

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201480008940.3A Pending CN105228632A (zh) 2013-02-15 2014-02-14 一种用以将一群治疗细胞维持在需要接受细胞治疗个体体内的治疗位置的方法

Country Status (3)

Country Link
EP (1) EP2964237A4 (fr)
CN (1) CN105228632A (fr)
WO (1) WO2014127232A2 (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2978109A1 (fr) * 2015-03-31 2016-10-06 The University Of North Carolina At Chapel Hill Vehicules d'apport pour cellules souches et leurs utilisations
US20170151416A1 (en) * 2015-12-01 2017-06-01 Invivo Therapeutics Corporation Methods and Systems for Delivery of a Trail of a Therapeutic Substance into an Anatomical Space
US10676634B2 (en) * 2018-09-05 2020-06-09 Swimc Llc Modified latent crosslinker in polymeric systems
IT201800020722A1 (it) * 2018-12-21 2020-06-21 Assunta Borzacchiello Biomateriale e suo utilizzo nel trattamento di patologie polmonari

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6482231B1 (en) * 1995-11-20 2002-11-19 Giovanni Abatangelo Biological material for the repair of connective tissue defects comprising mesenchymal stem cells and hyaluronic acid derivative
WO2004104166A2 (fr) * 2003-05-07 2004-12-02 La Jolla Institute For Molecular Medicine Methodes permettant de faciliter la recuperation de fonctions de cellules souches endogenes, implantees ou transplantees au moyen d'un acide hyaluronique de poids moleculaire eleve
WO2007070546A2 (fr) * 2005-12-14 2007-06-21 Anika Therapeutics, Inc. Implant méniscal de dérivés d'acide hyaluronique destiné au traitement de défauts méniscaux
US20090252700A1 (en) * 2003-01-10 2009-10-08 The Cleveland Clinic Foundation Hydroxyphenyl cross-linked macromolecular network and applications thereof
CN101855340A (zh) * 2007-03-06 2010-10-06 北卡罗来纳大学查珀尔希尔分校 用于细胞维持、扩增和/或分化的透明质酸、其他基质成分、激素和生长因子的复合物

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010127254A2 (fr) * 2009-04-30 2010-11-04 University Of Pittsburgh-Of The Commonwealth System Of Higher Education Matériau élastomère, biodégradable, thermosensible et utilisations de celui-ci
WO2011072399A1 (fr) * 2009-12-18 2011-06-23 The Governing Council Of The University Of Toronto Composition polymère injectable utilisée comme véhicule pour l'administration de cellules
KR101422689B1 (ko) * 2011-07-13 2014-07-23 (주)차바이오앤디오스텍 콜라겐, 히알루론산 유도체 및 포유류의 탯줄 유래 줄기세포를 포함하는 연골세포치료제

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6482231B1 (en) * 1995-11-20 2002-11-19 Giovanni Abatangelo Biological material for the repair of connective tissue defects comprising mesenchymal stem cells and hyaluronic acid derivative
US20090252700A1 (en) * 2003-01-10 2009-10-08 The Cleveland Clinic Foundation Hydroxyphenyl cross-linked macromolecular network and applications thereof
WO2004104166A2 (fr) * 2003-05-07 2004-12-02 La Jolla Institute For Molecular Medicine Methodes permettant de faciliter la recuperation de fonctions de cellules souches endogenes, implantees ou transplantees au moyen d'un acide hyaluronique de poids moleculaire eleve
WO2007070546A2 (fr) * 2005-12-14 2007-06-21 Anika Therapeutics, Inc. Implant méniscal de dérivés d'acide hyaluronique destiné au traitement de défauts méniscaux
CN101855340A (zh) * 2007-03-06 2010-10-06 北卡罗来纳大学查珀尔希尔分校 用于细胞维持、扩增和/或分化的透明质酸、其他基质成分、激素和生长因子的复合物

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
DREW KURAITIS 等: "Exploiting extracellular matrix-stem cell interactions: A review of natural materials for therapeutic muscle regeneration", 《BIOMATERIALS》 *
GAETANO LA MANNA 等: "Mesenchymal Stem Cells in Renal Function Recovery After Acute Kidney Injury: Use of a Differentiating Agent in a Rat Model", 《CELL TRANSPLANTATION》 *
GLENN D. PRESTWICH 等: "The translational imperative: Making cell therapy simple and effective", 《ACTA BIOMATERIALLA》 *
GLENN D. PRESTWICH: "Hyaluronic acid-based clinical biomaterials derived for cell and molecule delivery in regenerative medicine", 《JOURNAL OF CONTROLLEO RELEASE》 *

Also Published As

Publication number Publication date
EP2964237A4 (fr) 2016-11-30
WO2014127232A3 (fr) 2015-10-29
WO2014127232A2 (fr) 2014-08-21
EP2964237A2 (fr) 2016-01-13

Similar Documents

Publication Publication Date Title
Fan et al. An injectable oxygen release system to augment cell survival and promote cardiac repair following myocardial infarction
Schenke-Layland et al. Adipose tissue-derived cells improve cardiac function following myocardial infarction
KR101930718B1 (ko) 불사화 줄기세포 및 그 생산물을 유효 성분으로 하는 의약 조성물 및 의약 제제
ES2767182T3 (es) Células madre pluripotentes que inducen reparación y regeneración después de un infarto de miocardio
US20140106447A1 (en) Compositions and methods for recruiting stem cells
EP2902483B1 (fr) Procédé de prolifération in vitro d'une population cellulaire contenant des cellules appropriées pour traiter une maladie ischémique
Tang et al. The enhancement of endothelial cell therapy for angiogenesis in hindlimb ischemia using hyaluronan
US11351190B2 (en) Composition for treating tissue lesions
CN105228632A (zh) 一种用以将一群治疗细胞维持在需要接受细胞治疗个体体内的治疗位置的方法
Liu et al. Gelatin methacryloyl hydrogel scaffold loaded with activated Schwann cells attenuates apoptosis and promotes functional recovery following spinal cord injury
US20250115868A1 (en) Sequential application of macrophages for wound healing
Li et al. MG53/GMs/HA-Dex neural scaffold promotes the functional recovery of spinal cord injury by alleviating neuroinflammation
JP2012516853A (ja) 分化した内皮前駆細胞の治療的使用
JP7089283B2 (ja) 細胞製剤および細胞製剤の製造方法
US20150374741A1 (en) Methods for maintaining population of therapeutic cells in treatment site of subject in need of cell therapy
KR102250231B1 (ko) 심혈관 질환 예방 또는 치료용 조성물
Zinovyev et al. Experience of stem cell use in treatment of skin burns
RU2522816C1 (ru) Композиция для клеточно-заместительной терапии дефектов мягких тканей
KR102017386B1 (ko) 이식된 지방세포의 생착 증진용 조성물 및 지방 이식용 세포 치료제 조성물
Fang et al. Porous microneedle patch with sustained exosome delivery repairs severe spinal cord injury
US20220030851A1 (en) Modulating ischemic injury
Zhang et al. Lumbrokinase-loaded GelMA hydrogels with inflammatory regulatory capacity promote vascularized bone regeneration in critical-sized cranial defects
Burdzińska et al. Sodium ascorbate and basic fibroblast growth factor protect muscle-derived cells from H2O2-induced oxidative stress
US20260069745A1 (en) Biologic composition for promoting wound healing and a method of preparing the same
US20250345314A1 (en) Stem cell conjugated with rapamycin-containing drug carrier and uses thereof

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20160106

WD01 Invention patent application deemed withdrawn after publication